Signaling Pathways - DCLK2 - dopamine receptor - Valosin-containing protein (VCP) - Inward Rectifier Potassium (Kir) Channels
清除全部
- B6506 SCH 23390 hydrochlorideTarget: dopamine receptor|5-HT1 Receptor|5-HT2 ReceptorSummary: 多巴胺受体拮抗剂
- B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂
- B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂
- B2193 Mitiglinide Calcium中文名: 米格列奈钙Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂
- B1296 Glibenclamide中文名: 格列本脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素生产调节剂
- B2168 NMS-8733 CitationTarget: Valosin-containing protein (VCP)Summary: VCP/p97抑制剂
- A8534 Terfenadine中文名: 特非那定Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) ChannelsSummary: 组胺H1受体拮抗剂
- A3558 LRRK2-IN-11 CitationTarget: LRRK2|DCLK2Summary: LRRK2抑制剂
- A4033 Glimepiride中文名: 格列美脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 磺酰脲类化合物